Login / Signup

Dysfunction of the key ferroptosis-surveilling systems hypersensitizes mice to tubular necrosis during acute kidney injury.

Wulf TonnusClaudia MeyerChristian SteinebachAlexia BelavgeniAnne von MässenhausenNadia Zamora GonzalezFrancesca MaremontiFlorian GembardtNina HimmerkusMarkus LatkSophie LockeJulian MarschnerWenjun LiSpencer ShortSebastian DollIrina IngoldBettina PronethChristoph DanielNazanin KabganiRafael KramannStephen MotikaPaul J HergenrotherStefan R BornsteinChristian HugoJan Ulrich BeckerKerstin AmannHans-Joachim AndersDaniel KreiselDerek A PrattMichael GütschowMarcus ConradAndreas Linkermann
Published in: Nature communications (2021)
Acute kidney injury (AKI) is morphologically characterized by a synchronized plasma membrane rupture of cells in a specific section of a nephron, referred to as acute tubular necrosis (ATN). Whereas the involvement of necroptosis is well characterized, genetic evidence supporting the contribution of ferroptosis is lacking. Here, we demonstrate that the loss of ferroptosis suppressor protein 1 (Fsp1) or the targeted manipulation of the active center of the selenoprotein glutathione peroxidase 4 (Gpx4cys/-) sensitize kidneys to tubular ferroptosis, resulting in a unique morphological pattern of tubular necrosis. Given the unmet medical need to clinically inhibit AKI, we generated a combined small molecule inhibitor (Nec-1f) that simultaneously targets receptor interacting protein kinase 1 (RIPK1) and ferroptosis in cell lines, in freshly isolated primary kidney tubules and in mouse models of cardiac transplantation and of AKI and improved survival in models of ischemia-reperfusion injury. Based on genetic and pharmacological evidence, we conclude that GPX4 dysfunction hypersensitizes mice to ATN during AKI. Additionally, we introduce Nec-1f, a solid inhibitor of RIPK1 and weak inhibitor of ferroptosis.
Keyphrases